Breakthrough cell therapy shows promise in treating multiple solid tumours
Labiotech - 14-Sep-2022LIfT Biosciences' N-LIfT therapy targets and destroys tumours with a unique immune-based approach
Join the club for FREE to access the whole archive and other member benefits.
Senior Editor at Labiotech
Liza Laws is the Senior Editor at Labiotech, bringing over 20 years of expertise in journalism, public relations, and digital communications. Known for her ability to craft engaging content that resonates with audiences, Liza has a proven track record of driving impactful PR strategies and making major editorial decisions under tight deadlines. Her strengths span communication, problem-solving, interpersonal relations, and management, developed through diverse roles including leading PR for a multi-office law firm and serving as a deputy editor for a lifestyle magazine. With a strategic mindset and a personable approach, Liza excels at creating compelling stories and building strong networks in the biotech and media landscape.
Visit website: https://www.labiotech.eu/author/lizalaws/
See alsoDetails last updated 06-Nov-2024
LIfT Biosciences' N-LIfT therapy targets and destroys tumours with a unique immune-based approach